Delivery Order SPE2DB20D3103-SPE2DB23FN4W7
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $3,366.30 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JARDIANCE 10 MG TABLET 30S, a medication used to manage diabetes. This Delivery Order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC serves...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $10,824.85 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a firm fixed price, covers the delivery of Jardiance 25 mg tablets through January 7, 2025. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $8,275.58 to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of Jardiance 25 mg tablets, a pharmaceutical product used to treat diabetes. The contract has a firm fixed-price pricing structure and does not have a set-aside designation. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., will provide the medication to support military...
- The Defense Logistics Agency (DLA) awarded a $9,008.43 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply the medication Jardiance 10 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally....
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $13,135.43 firm fixed price delivery order contract for the provision of Jardiance 10 mg tablets. This order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $12,782.91 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Jardiance 10 mg tablets. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to AmerisourceBergen Drug Corp. The IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $13,193.59 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,029,949 tablets of the medication Jardiance 10 mg. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,633.29 delivery order contract is for the provision of Jardiance 25 mg tablets, a diabetes treatment medication. The contract is a firm fixed-price, non-set-aside award with a completion date of May 8, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,379.23 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Jardiance 10 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $6,826.53 contract is for the delivery of Jardiance 25 mg tablets to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN4W7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $4,463.18 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen, with the DLA Troop Support Medical worth up to $999,999,999. The IDC serves as the primary vehicle for AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, through its extensive supply chain and distribution capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 5/23/23 |